Home Healthcare IT Peptide Therapeutics Market

Peptide Therapeutics Market Size, Share & Trends Analysis Report By Application (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Anti-infection, Pain, Dermatology, CNS, Renal), By Type (Generic, Innovative), By Type of Manufacturers (In-house, Outsourced), By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal), By Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SRHI2277DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends
  8. Global Peptide Therapeutics Market Size Analysis
    1. Global Peptide Therapeutics Market Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. U.S.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. U.K.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. China
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. UAE
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. Brazil
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
  14. Competitive Landscape
    1. Peptide Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. Eli Lilly and Company
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc.
    3. Amgen Inc.
    4. Takeda Pharmaceutical Company Limited
    5. Teva Pharmaceuticals Industries Ltd.
    6. Lonza Inc.
    7. Sanofi
    8. Bristol-Myers Squibb (BMS)
    9. AstraZeneca PLC
    10. GlaxoSmithKline plc (GSK)
    11. Novartis AG
    12. Novo Nordisk A/S
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.